De Vivo I - Search Results

1

Plasma vitamin D biomarkers and leukocyte telomere length.

Liu JJ, Prescott J, Giovannucci E, Hankinson SE, Rosner B, Han J, De Vivo I. Liu JJ, et al. Among authors: de vivo i. Am J Epidemiol. 2013 Jun 15;177(12):1411-7. doi: 10.1093/aje/kws435. Epub 2013 May 9. Am J Epidemiol. 2013. PMID: 23660800 Free PMC article.

2

Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers.

De Vivo I, Gertig DM, Nagase S, Hankinson SE, O'Brien R, Speizer FE, Parsons R, Hunter DJ. De Vivo I, et al. J Med Genet. 2000 May;37(5):336-41. doi: 10.1136/jmg.37.5.336. J Med Genet. 2000. PMID: 10807691 Free PMC article.

3

A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk.

Haiman CA, Hankinson SE, Spiegelman D, De Vivo I, Colditz GA, Willett WC, Speizer FE, Hunter DJ. Haiman CA, et al. Among authors: de vivo i. Int J Cancer. 2000 Jul 15;87(2):204-10. Int J Cancer. 2000. PMID: 10861475 Free article.

4

A polymorphism in CYP17 and endometrial cancer risk.

Haiman CA, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I. Haiman CA, et al. Among authors: de vivo i. Cancer Res. 2001 May 15;61(10):3955-60. Cancer Res. 2001. PMID: 11358812

5

Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels.

Guillemette C, De Vivo I, Hankinson SE, Haiman CA, Spiegelman D, Housman DE, Hunter DJ. Guillemette C, et al. Among authors: de vivo i. Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):711-4. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11401924

6

Association of CYP1B1 polymorphisms and breast cancer risk.

De Vivo I, Hankinson SE, Li L, Colditz GA, Hunter DJ. De Vivo I, et al. Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):489-92. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12010864

7

A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk.

De Vivo I, Huggins GS, Hankinson SE, Lescault PJ, Boezen M, Colditz GA, Hunter DJ. De Vivo I, et al. Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12263-8. doi: 10.1073/pnas.192172299. Epub 2002 Sep 6. Proc Natl Acad Sci U S A. 2002. PMID: 12218173 Free PMC article.

8

No association between a stop codon polymorphism in RAD52 and breast cancer risk.

Han J, Hankinson SE, De Vivo I, Colditz GA, Hunter DJ. Han J, et al. Among authors: de vivo i. Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1138-9. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12376524 No abstract available.

9

Polymorphisms in steroid hormone pathway genes and mammographic density.

Haiman CA, Hankinson SE, De Vivo I, Guillemette C, Ishibe N, Hunter DJ, Byrne C. Haiman CA, et al. Among authors: de vivo i. Breast Cancer Res Treat. 2003 Jan;77(1):27-36. doi: 10.1023/a:1021112121782. Breast Cancer Res Treat. 2003. PMID: 12602902

10

A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk.

De Vivo I, Hankinson SE, Colditz GA, Hunter DJ. De Vivo I, et al. Cancer Res. 2003 Sep 1;63(17):5236-8. Cancer Res. 2003. PMID: 14500352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

323 results

Search Page